Edition:
United Kingdom

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

5.65USD
19 Jun 2019
Change (% chg)

$0.01 (+0.18%)
Prev Close
$5.64
Open
$5.69
Day's High
$5.70
Day's Low
$5.62
Volume
2,675
Avg. Vol
12,040
52-wk High
$9.80
52-wk Low
$3.35

About

Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istiratumab) and MM-310. MM-121 is a fully human monoclonal antibody that binds to the... (more)
No analyst recommendations are available for .

Overall

Beta: 2.21
Market Cap(Mil.): $75.52
Shares Outstanding(Mil.): 13.34
Dividend: --
Yield (%): --

Financials

  MACK.OQ Industry Sector
P/E (TTM): -- 104.93 37.25
EPS (TTM): -4.00 -- --
ROI: -74.87 7.73 12.15
ROE: -83.21 8.25 16.99

Earnings vs. Estimates